# VERONA PHARMA PLC (VRNA)

> Institutional ownership reported to the SEC as of Q4 2025, from Form 13F filings. Source: https://holderbook.com/stocks/VRNA/

- Reporting holders: 1
- Reported value: $359.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [DekaBank Deutsche Girozentrale](https://holderbook.com/funds/1456228-dekabank-deutsche-girozentrale/) | $359.0K | 20,000 | 0.0% | 13 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q4 2025 | 1 | $359.0K |
| Q3 2025 | 247 | $8.9B |
| Q2 2025 | 298 | $7.6B |
| Q1 2025 | 263 | $4.8B |
| Q4 2024 | 201 | $3.3B |
| Q3 2024 | 153 | $2.0B |
| Q2 2024 | 129 | $979.9M |
| Q1 2024 | 114 | $1.1B |
| Q4 2023 | 118 | $1.4B |
| Q3 2023 | 101 | $1.1B |
| Q2 2023 | 105 | $1.3B |
| Q1 2023 | 100 | $1.3B |